All medications come from licensed 503A compounding pharmacies, require no insurance, and are HSA/FSA eligible
42 VijayalingamS.ParthibanA.ShanmugasundaramK.MohanV
"In people with type 2 diabetes, tirzepatide 5, 10, and 15 mg were more efficacious in reducing HbA1c compared to semaglutide 0.5, 1.0, and 2.0 mg, respectively," the authors write.
A provider would need to confirm how multiple earlier, lower levels were tolerated before a high figure like this could reasonably be discussed
Those comments were made by participants in two trialsSURPASS-2 and SURPASS-3that gave a new drug called tirzepatide (sold by Eli Lilly as Mounjaro) to people with type 2 diabetes
The researchers successfully used the peptide to decrease levels of chromosome aberrations in the mice, observing that treatment with melatonin had no such effect [4]